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Background
Cartilage-hair hypoplasia (CHH) is a rare autosomal
recessive disorder characterized by short-limbed skeletal
dysplasia. Some patients also develop defects in cell-
mediated immunity and antibody production. Granulo-
matous inflammation has been described in patients
with various forms of primary immunodeficiencies but,
to date, has not been reported in patients with Carti-
lage-hair hypoplasia.
Aims
To describe granulomatous inflammation as a novel fea-
ture in patients with CHH, assess associated immunode-
ficiency and evaluate treatment options.
Methods
In a retrospective, observational study, we collected clin-
ical data on 21 patients with CHH in order to identify
and further characterize individuals with granulomatous
inflammation.
Results
Four unrelated patients with CHH (with variable degrees
of combined immunodeficiency) developed epithelioid
cell granulomatous inflammation in the skin and visceral
organs. Anti Tumor necrosis factor alpha monoclonal
antibody therapy in 3 of these patients led to significant
regression of granulomas. However, one treated patient
developed fatal progressive multifocal leukoencephalopa-
thy due to the JC polyomavirus. In two patients,
immune reconstitution after allogeneic hematopoietic
stem cell transplantation led to the complete disappear-
ance of granulomas.
Conclusion
To the best of our knowledge, this is the first report of
granulomatous inflammation in patients with CHH.
Although Tumor necrosis factor alpha antagonists may
effectively suppress granulomas, the risk of severe infec-
tious complications limits their use in immunodeficient
patients.
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